- Clean Harbors, Inc. received an average consensus rating of Moderate Buy from seventeen research firms with a 12 month target price of $354.5714.
- The company reported strong quarterly earnings of $3.22 EPS and revenue of $1.74 billion, representing an 11.9% increase year over year.
- Several institutional investors adjusted their holdings, while insiders sold a total of 4,078 shares over the last three months.
- Csenge Advisory Group purchased 31,896 shares of Bank of America Corporation valued at approximately $1,817,000 during the second quarter.
- Bank of America reported quarterly earnings of $1.21 per share with revenue of $31.56 billion, surpassing analysts' expectations.
- The company announced an increased quarterly dividend of $0.32 per share, payable on September 25, 2026.
- Neostellar Capital has received a consensus rating of "Buy" from 6 ratings firms, with an average 1-year price objective of $14.50.
- The company opened at $10.01 on Monday, holding a market cap of $264.96 million and reporting an EPS of ($0.90) for the quarter.
- CEO Mark D. Klein purchased 26,040 shares for a total value of $249,984.00, while several hedge funds adjusted their positions in the stock.
- Bank of America Corporation experienced recent stock purchases by institutional investors alongside strong second-quarter financial results featuring EPS of $1.21 and revenue of $31.56 billion.
- The company also raised its quarterly dividend to $0.28 and received multiple target price increases from equities research analysts.
- These developments occurred alongside diverse market sentiments driven by bond market activity and strategic stake adjustments in global firms.
- Mastercard Incorporated experienced increased institutional and insider stock activity alongside strong second-quarter financial results featuring EPS of $5.04 and revenue of $9.28 billion.
- The global payments technology company is expanding its strategic focus into emerging markets like AI-driven agentic payments while navigating mixed market valuations and potential UK litigation risks.
- Major financial institutions maintain a consensus "Buy" rating on the stock with an average price target of $661.93.
- Bank of America increased its stake in Structure Therapeutics by 617.0% in the first quarter, owning 227,132 shares valued at $10,948,000.
- Several institutional investors and hedge funds also adjusted their positions, with 91.78% of the stock currently owned by institutional investors and hedge funds.
- Structure Therapeutics reported quarterly earnings of ($0.49) per share, while maintaining a consensus rating of Moderate Buy among analysts with an average price target of $110.91.